The Non-Invasive Neural Race: Why Apple Absorbed Sonera to Bypass the Skin Barrier
Dr. Dereck Mush, MD, MBA
What they do
Mailian Medical raised 100M RMB (about $14M) in a Series B in October 2026. The first Chinese company to hold a registration certificate for BCI motor rehabilitation, it has six Class II device certificates, equipment in more than 150 hospitals and over 100,000 patients treated, and is extending care from hospitals into community and home rehabilitation.
The record
- Vertical
- Neurotech
- Sub-segment
- Non-invasive BCI rehabilitation
- Product type
- Medical device
- Stage
- Series B
- Headquarters
- Zhejiang, China
- Region
- Asia-Pacific
- Founded
- 2018
- Total funding
- $14M raised
Notable investors: Chuangda Industrial Holdings, Jinshajiang United Capital.
Related on The Signal
Dr. Dereck Mush, MD, MBA
New diagnostic tools are trying to shrink endometriosis's decade long diagnosis gap
Dr. Dereck Mush, MD, MBA
The $1.65B Non-Opioid Consolidation: How the NOPAIN Act and Viatris' Buyout Reshape Hospital Analgesic Economics
Dr. Dereck Mush, MD, MBA
The Coronary Plaque Reimbursement Playbook: Inside Elucid's $55M Raise and the Economics of Non-Invasive Cardiovascular AI
Dr. Dereck Mush, MD, MBA